Your session is about to expire
← Back to Search
Group 3: ECG+SpO2+RFM+NIRS for Premature Infants
N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during resuscitation
Awards & highlights
Study Summary
This trial is designed to study if adding machines that measure how well a baby is breathing during resuscitation (RFM and cNIRS) increases how stressed healthcare providers feel, and makes it harder for them to focus on the task.
Eligible Conditions
- Premature Infants
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Team Leader's NASA Task Load Index (NASA-TLX) Mental Demand
Secondary outcome measures
Composite team mental workload
Frequency of visual fixation to monitoring equipment Visual Access to each monitor display type (vital signs, RFM, NIRS)
Severe Bronchopulmonary Dysplasia
+7 moreTrial Design
3Treatment groups
Active Control
Group I: Group 3: ECG+SpO2+RFM+NIRSActive Control2 Interventions
Addition of cerebral NIRS and Respiratory Function Monitor to ECG and SpO2 during resuscitation.
Group II: Group 2: ECG+SpO2+RFMActive Control1 Intervention
Addition of Respiratory Function Monitor to ECG and SpO2 during resuscitation.
Group III: Group1: ECG+SpO2 onlyActive Control1 Intervention
Traditional ECG (heart rate) and SpO2 (pulse oximetry) monitoring for resuscitation only.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,087 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger